300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Construction
Marketplace
Retail
Film
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Europe
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Qatar
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Angola
Cyprus
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Alun Williams, Investment Director at Parkwalk Advisors

Alun Williams

Investment Director @ Parkwalk Advisors

London, United Kingdom

Alun Williams is a Series A investor at Parkwalk Advisors in London focused on Software and Health Care. Alun Williams joined Parkwalk Advisors as Investment Director in 2014.

Total investments:
17
Last investment:
Lead investor:
35%

Last updated:

Industries Alun Williams invests in

SoftwareHealth CareArtificial IntelligenceSensorFinance

Stages Alun Williams invests in

Series ASeedSeries BSeries CSeries D

Countries Alun Williams invests in

United Kingdom

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Software 2 (12%)
  • Health Care 2 (12%)
  • Artificial Intelligence 2 (12%)
  • Sensor 1 (6%)
  • Finance 1 (6%)
See all 17 industries →

Stage

  • Series A 4 (24%)
  • Seed 3 (18%)
  • Series B 1 (6%)
  • Series C 1 (6%)
  • Series D 1 (6%)
See all 8 stages →

Investments

CompanyDescriptionRoundLinks
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs).These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking.It is hoped thatCeryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury. $6.8M / Venture - Series Unknown / Jun 11, 2025
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal. $10.2M / Series A / May 20, 2024
Proxisense has developed extreme environment proximity sensors and fluid contamination systems utilising eddy current sensors. The former are finding uses in producing systems which monitor the health of turbine blades in real-time, which can extend component lifetimes and reduce maintenance and downtime costs. Proxisense is targeting the power andaerospace industries for these use cases and is working closely with major OEM players in the fields, including Alstom, Siemens and Rolls-Royce. Contamination of critical fluid systems is a significant issue where transportation assets travel the world and require fuel and lubrication fluids from remote sources. Proxisense’s system can provide real-time, reliable monitoring of these fluids and reduce damage to components, sub-optimal operating conditions and, potentially, system failures. $1.3M / Series A / Nov 24, 2023
Textmine is an E2E AI powered knowledge base for your business critical documents (things like invoices, payslips, tender documents, compliance reports and even contracts). We consolidate everything into a single operational layer to enable proactive decision making. We give Increased data transparency, whilst allowing document creation to bemore scalable and uniform. We’ve helped organisations save money and time whilst reducing their risk profile and increasing compliance. $3.6M / Seed / Mar 14, 2023
Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology which is able to mimic nerve centres within the body called Central Pattern Generators (CPGs).These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking.It is hoped thatCeryx’s artificial CPGs can restore normal performance where these processes have been affected by disease or injury. $4.8M / Seed / Apr 27, 2022
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal. $9.9M / Series A / Apr 08, 2021
Textmine is an E2E AI powered knowledge base for your business critical documents (things like invoices, payslips, tender documents, compliance reports and even contracts). We consolidate everything into a single operational layer to enable proactive decision making. We give Increased data transparency, whilst allowing document creation to bemore scalable and uniform. We’ve helped organisations save money and time whilst reducing their risk profile and increasing compliance. $1.4M / Seed / Mar 11, 2021
Mind Foundry is an Oxford University Company. Operating at the intersection of innovation and usability, Mind Foundry empowers organisations through the use of Responsible AI built to tackle high-stakes, real-world problems at both individual and population scale. Mind Foundry’s AI Platform and technologies have been used to solve some of the mostchallenging applications of Machine Learning, from insurance fraud detection to complex signal processing, helping customers in insurance, infrastructure, and defence and security tackle the issues that matter most to them whilst promoting the responsible and transparent usage of AI. Founded by pioneers in the field of AI and Machine Learning, Oxford Professors Stephen Roberts and Michael Osborne, the mission of Mind Foundry is to create a future where humans and AI work together to solve the world’s most important problems. $6.2M / Series A / Jun 26, 2020
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally.We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when youneed it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life. $3.9M / Series F / Jan 17, 2020
Mind Foundry is an Oxford University Company. Operating at the intersection of innovation and usability, Mind Foundry empowers organisations through the use of Responsible AI built to tackle high-stakes, real-world problems at both individual and population scale. Mind Foundry’s AI Platform and technologies have been used to solve some of the mostchallenging applications of Machine Learning, from insurance fraud detection to complex signal processing, helping customers in insurance, infrastructure, and defence and security tackle the issues that matter most to them whilst promoting the responsible and transparent usage of AI. Founded by pioneers in the field of AI and Machine Learning, Oxford Professors Stephen Roberts and Michael Osborne, the mission of Mind Foundry is to create a future where humans and AI work together to solve the world’s most important problems. $6M / Seed / Mar 13, 2019
See all 17 investments →

Co-Investors

Parkwalk Advisors

About Parkwalk Advisors

VC Fund · London, United Kingdom

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Parkwalk Advisors Contacts

NameEmailPhoneSocials
Alastair Kilgour
Alastair Kilgour Co-Founder and Partner
Alun Williams
Alun Williams Investment Director
Chloe Richardson
Chloe Richardson Investor Relations Manager
Douglas Wright
Douglas Wright CEO and Co-Founder
Enrico D'Angelo
Enrico D'Angelo Finance Director

Sign up to unlock verified contacts

Unlock Contacts

See all 11 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Construction
Marketplace
Retail
Film
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Europe
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Qatar
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Angola
Cyprus
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Alun Williams invest in?

Alun Williams invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 17 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Alun Williams?

Public channels for Alun Williams include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Alun Williams last invest?

The most recent investment recorded for Alun Williams closed in Jun 2025. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Alun Williams Alun Williams Find email